Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages

Alpha Teknova, Inc. (NASDAQ:TKNO) has earned a consensus rating of “Moderate Buy” from the six brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $8.75.

A number of equities research analysts have recently weighed in on the stock. BTIG Research raised shares of Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 target price on the stock in a research note on Tuesday, August 11th. TD Cowen increased their price target on shares of Alpha Teknova from $7.00 to $11.00 and gave the stock a “buy” rating in a research note on Tuesday, October 13th. Roth Capital assumed coverage on shares of Alpha Teknova in a report on Wednesday, August 5th. They issued a “buy” rating and a $7.00 price objective for the company. Jefferies Financial Group started coverage on shares of Alpha Teknova in a report on Thursday, September 17th. They issued a “buy” rating and a $9.00 price objective for the company. Finally, Wall Street Zen raised Alpha Teknova from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th.

Alpha Teknova Stock Performance

NASDAQ:TKNO opened at $8.30 on Friday. The stock has a market cap of $522.07 million, a P/E ratio of -28.62 and a beta of 0.96. The firm’s fifty day simple moving average is $7.83 and its 200 day simple moving average is $5.09. Alpha Teknova has a twelve month low of $1.91 and a twelve month high of $9.48. The company has a quick ratio of 3.48, a current ratio of 3.56 and a debt-to-equity ratio of 0.22.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Wednesday, November 4th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Alpha Teknova had a negative net margin of 34.76% and a negative return on equity of 24.95%. The business had revenue of $12.70 million for the quarter, compared to the consensus estimate of $11.71 million. As a group, research analysts predict that Alpha Teknova will post -0.26 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in TKNO. Deutsche Bank AG bought a new stake in shares of Alpha Teknova during the second quarter valued at approximately $62,000. Ieq Capital LLC purchased a new stake in Alpha Teknova in the second quarter worth $62,000. R Squared Ltd bought a new position in Alpha Teknova in the first quarter worth $42,000. Susquehanna International Group LLP bought a new position in Alpha Teknova in the second quarter worth $115,000. Finally, Fielder Capital Group LLC bought a new position in Alpha Teknova in the second quarter worth $143,000. Institutional investors own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.